Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProPit: Pitavastatin in Metabolic Syndrome
NCT00640276Phase 4Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Apr 2008
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pitavastatin in metabolic syndrome, hypercholesterolemia, sponsored by JW Pharmaceutical Corporation. Started Apr 2008; status: completed.
02
Drugs
pitavastatin
03
Conditions
metabolic syndromehypercholesterolemia
Beyond the preview
Go deeper on NCT00640276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640276.